View Future GrowthKingfa Science & Technology (India) 過去の業績過去 基準チェック /46Kingfa Science & Technology (India)は、平均年間42.5%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 成長しています。収益は、平均年間6.7% 18.5%収益成長率で 成長しています。 Kingfa Science & Technology (India)の自己資本利益率は13%であり、純利益率は8.9%です。主要情報42.55%収益成長率41.76%EPS成長率Chemicals 業界の成長17.68%収益成長率18.48%株主資本利益率12.98%ネット・マージン8.91%前回の決算情報31 Dec 2025最近の業績更新Reported Earnings • Feb 08Third quarter 2026 earnings released: EPS: ₹33.34 (vs ₹28.59 in 3Q 2025)Third quarter 2026 results: EPS: ₹33.34 (up from ₹28.59 in 3Q 2025). Revenue: ₹4.89b (up 11% from 3Q 2025). Net income: ₹451.7m (up 31% from 3Q 2025). Profit margin: 9.2% (up from 7.9% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Feb 02Kingfa Science & Technology (India) Limited to Report Q3, 2026 Results on Feb 07, 2026Kingfa Science & Technology (India) Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 07, 2026分析記事 • Nov 20Kingfa Science & Technology (India)'s (NSE:KINGFA) Earnings Are Weaker Than They SeemDespite announcing strong earnings, Kingfa Science & Technology (India) Limited's ( NSE:KINGFA ) stock was sluggish. We...Reported Earnings • Nov 14Second quarter 2026 earnings released: EPS: ₹30.36 (vs ₹30.76 in 2Q 2025)Second quarter 2026 results: EPS: ₹30.36. Revenue: ₹4.68b (up 12% from 2Q 2025). Net income: ₹411.4m (up 10% from 2Q 2025). Profit margin: 8.8% (down from 8.9% in 2Q 2025). The decrease in margin was driven by higher expenses.お知らせ • Nov 07Kingfa Science & Technology (India) Limited to Report Q2, 2026 Results on Nov 12, 2025Kingfa Science & Technology (India) Limited announced that they will report Q2, 2026 results on Nov 12, 2025Reported Earnings • Jul 31First quarter 2026 earnings released: EPS: ₹32.86 (vs ₹32.27 in 1Q 2025)First quarter 2026 results: EPS: ₹32.86 (up from ₹32.27 in 1Q 2025). Revenue: ₹4.66b (up 12% from 1Q 2025). Net income: ₹397.9m (up 1.8% from 1Q 2025). Profit margin: 8.5% (down from 9.4% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.すべての更新を表示Recent updatesReported Earnings • Feb 08Third quarter 2026 earnings released: EPS: ₹33.34 (vs ₹28.59 in 3Q 2025)Third quarter 2026 results: EPS: ₹33.34 (up from ₹28.59 in 3Q 2025). Revenue: ₹4.89b (up 11% from 3Q 2025). Net income: ₹451.7m (up 31% from 3Q 2025). Profit margin: 9.2% (up from 7.9% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Feb 02Kingfa Science & Technology (India) Limited to Report Q3, 2026 Results on Feb 07, 2026Kingfa Science & Technology (India) Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 07, 2026Buy Or Sell Opportunity • Jan 29Now 20% overvaluedOver the last 90 days, the stock has fallen 9.1% to ₹4,225. The fair value is estimated to be ₹3,515, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.分析記事 • Dec 23Kingfa Science & Technology (India) Limited (NSE:KINGFA) Not Flying Under The RadarKingfa Science & Technology (India) Limited's ( NSE:KINGFA ) price-to-earnings (or "P/E") ratio of 37x might make it...Buy Or Sell Opportunity • Dec 22Now 20% overvaluedOver the last 90 days, the stock has fallen 2.3% to ₹4,284. The fair value is estimated to be ₹3,567, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.分析記事 • Dec 05Kingfa Science & Technology (India) (NSE:KINGFA) Is Doing The Right Things To Multiply Its Share PriceIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Buy Or Sell Opportunity • Nov 27Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 5.0% to ₹4,382. The fair value is estimated to be ₹3,589, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.分析記事 • Nov 20Kingfa Science & Technology (India)'s (NSE:KINGFA) Earnings Are Weaker Than They SeemDespite announcing strong earnings, Kingfa Science & Technology (India) Limited's ( NSE:KINGFA ) stock was sluggish. We...Reported Earnings • Nov 14Second quarter 2026 earnings released: EPS: ₹30.36 (vs ₹30.76 in 2Q 2025)Second quarter 2026 results: EPS: ₹30.36. Revenue: ₹4.68b (up 12% from 2Q 2025). Net income: ₹411.4m (up 10% from 2Q 2025). Profit margin: 8.8% (down from 8.9% in 2Q 2025). The decrease in margin was driven by higher expenses.お知らせ • Nov 07Kingfa Science & Technology (India) Limited to Report Q2, 2026 Results on Nov 12, 2025Kingfa Science & Technology (India) Limited announced that they will report Q2, 2026 results on Nov 12, 2025お知らせ • Sep 30Kingfa Science & Technology (India) Limited Approves Appointment of Subramanyan S. K. as A Non-Executive Independent DirectorKingfa Science & Technology (India) Limited announced that at the AGM held on September 29, 2025, approved appointment of Mr. Subramanyan S. K. (DIN:00024614) as a Non-Executive Independent Director.お知らせ • Sep 25Kingfa Science & Technology (India) Limited announced that it has received INR 4.9999924 billion in funding from Sanshi Fund - I, Custody Bank of Japan, Ltd. RE: RB Amundi Small Cap Equity Mother Fund, SBI Optimal Equity Fund - Long Term, SBI Funds Management LimitedOn September 24, 2025, Kingfa Science & Technology (India) Limited closed the transaction. The company issued 1,440,920 equity shares at an issue price of INR 3,470 for gross proceeds of INR 4,999,992,400. The transaction includes participation from new investors, Sanshi Fund - I for 72,046 shares and will acquire 0.53% stake, SBI Mutual Fund - SBI Flexicap Fund, a fund managed by SBI Funds Management Limited for 345,821 shares and will acquire 2.55% stake, SBI Funds Management Limited - SBI Automotive Opportunities Fund, a fund managed by SBI Funds Management Limited for 184,438 shares and will acquire 1.36% stake, SBI Conservative Hybrid Fund, a fund managed by SBI Funds Management Limited for 357,348 shares and will acquire 2.64% stake, Custody Bank of Japan, Ltd. RE: RB Amundi Small Cap Equity Mother Fund for 273,775 shares and will acquire 2.02% stake, SBI Optimal Equity Fund - Long Term for 100,864 shares and will acquire 0.74% stake and Sbi Emergent India Fund, a fund managed by SBI Funds Management Limited for 106,628 shares and will acquire 0.79% stake. The transaction has been approved by the board of directors.New Risk • Sep 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.お知らせ • Aug 25Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 29, 2025Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 29, 2025, at 11:30 Indian Standard Time.分析記事 • Aug 20Kingfa Science & Technology (India) Limited (NSE:KINGFA) Looks Just Right With A 27% Price JumpNSEI:KINGFA 1 Year Share Price vs Fair Value Explore Kingfa Science & Technology (India)'s Fair Values from the...Valuation Update With 7 Day Price Move • Aug 18Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹4,145, the stock trades at a trailing P/E ratio of 32.7x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 328% over the past three years.分析記事 • Aug 02We Like Kingfa Science & Technology (India)'s (NSE:KINGFA) Returns And Here's How They're TrendingDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...Reported Earnings • Jul 31First quarter 2026 earnings released: EPS: ₹32.86 (vs ₹32.27 in 1Q 2025)First quarter 2026 results: EPS: ₹32.86 (up from ₹32.27 in 1Q 2025). Revenue: ₹4.66b (up 12% from 1Q 2025). Net income: ₹397.9m (up 1.8% from 1Q 2025). Profit margin: 8.5% (down from 9.4% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jul 23Kingfa Science & Technology (India) Limited to Report Q1, 2026 Results on Jul 30, 2025Kingfa Science & Technology (India) Limited announced that they will report Q1, 2026 results on Jul 30, 2025分析記事 • Jul 01Kingfa Science & Technology (India) Limited's (NSE:KINGFA) Subdued P/E Might Signal An OpportunityThere wouldn't be many who think Kingfa Science & Technology (India) Limited's ( NSE:KINGFA ) price-to-earnings (or...Reported Earnings • May 29Full year 2025 earnings released: EPS: ₹126 (vs ₹101 in FY 2024)Full year 2025 results: EPS: ₹126 (up from ₹101 in FY 2024). Revenue: ₹17.5b (up 18% from FY 2024). Net income: ₹1.53b (up 25% from FY 2024). Profit margin: 8.7% (up from 8.2% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 47% per year whereas the company’s share price has increased by 52% per year.お知らせ • May 20Kingfa Science & Technology (India) Limited to Report Q4, 2025 Results on May 28, 2025Kingfa Science & Technology (India) Limited announced that they will report Q4, 2025 results on May 28, 2025お知らせ • Apr 01Kingfa Science & Technology (India) Limited Announces Resignation of Nirnoy Sur as Company Secretary & Compliance Officer, Effective March 31, 2025Kingfa Science & Technology (India) Limited informed that Mr. Nirnoy Sur has resigned as Company Secretary & Compliance Officer of the Company with effect from March 31,2025. Mr. Nirnoy Sur has tendered his resignation from the position of Company Secretary (Key Managerial Personnel), Compliance Officer and Nodal Officer of the Company vide letter dated February 11, 2025, due to his personal reasons and to pursue professional growth opportunities.Reported Earnings • Feb 13Third quarter 2025 earnings released: EPS: ₹28.59 (vs ₹20.09 in 3Q 2024)Third quarter 2025 results: EPS: ₹28.59 (up from ₹20.09 in 3Q 2024). Revenue: ₹4.40b (up 12% from 3Q 2024). Net income: ₹346.3m (up 42% from 3Q 2024). Profit margin: 7.9% (up from 6.2% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 11Kingfa Science & Technology (India) Limited Announces Resignation of Nirnoy Sur as Company Secretary, Effective March 31, 2025Kingfa Science & Technology (India) Limited approved Resignation of Mr. Nirnoy Sur as Company Secretary & Compliance Officer of the Company. Reason for Change: Resignation, due to his personal reasons and to pursue professional growth opportunities. Date of Cessation: March 31, 2025. Resignation letter date: February 11, 2025.お知らせ • Feb 03Kingfa Science & Technology (India) Limited to Report Q3, 2025 Results on Feb 11, 2025Kingfa Science & Technology (India) Limited announced that they will report Q3, 2025 results on Feb 11, 2025分析記事 • Jan 15Here's Why Kingfa Science & Technology (India) (NSE:KINGFA) Can Manage Its Debt ResponsiblyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • Dec 24We Like Kingfa Science & Technology (India)'s (NSE:KINGFA) Returns And Here's How They're TrendingTo find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...Valuation Update With 7 Day Price Move • Dec 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹3,363, the stock trades at a trailing P/E ratio of 30.3x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 265% over the past three years.分析記事 • Dec 04Kingfa Science & Technology (India) Limited (NSE:KINGFA) Might Not Be As Mispriced As It LooksThere wouldn't be many who think Kingfa Science & Technology (India) Limited's ( NSE:KINGFA ) price-to-earnings (or...Reported Earnings • Oct 30Second quarter 2025 earnings released: EPS: ₹30.76 (vs ₹24.44 in 2Q 2024)Second quarter 2025 results: EPS: ₹30.76 (up from ₹24.44 in 2Q 2024). Revenue: ₹4.19b (up 20% from 2Q 2024). Net income: ₹372.6m (up 26% from 2Q 2024). Profit margin: 8.9% (up from 8.4% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 47% per year, which means it is significantly lagging earnings growth.お知らせ • Oct 21Kingfa Science & Technology (India) Limited to Report Q2, 2025 Results on Oct 29, 2024Kingfa Science & Technology (India) Limited announced that they will report Q2, 2025 results on Oct 29, 2024お知らせ • Sep 26Kingfa Science & Technology (India) Limited Approves Dividend for the Financial Year Ended March 31, 2024Kingfa Science & Technology (India) Limited at its AGM held on 25 September 2024 approved, Declaration of Dividend of INR 10/- per Equity Share of the face value of INR 10/- each (100%), of the Company for the financial year ended March 31, 2024.Upcoming Dividend • Sep 11Upcoming dividend of ₹10.00 per shareEligible shareholders must have bought the stock before 18 September 2024. Payment date: 24 October 2024. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.0%). Lower than average of industry peers (0.6%).お知らせ • Aug 29Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 25, 2024Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 25, 2024, at 11:30 Indian Standard Time.分析記事 • Aug 21Market Might Still Lack Some Conviction On Kingfa Science & Technology (India) Limited (NSE:KINGFA) Even After 43% Share Price BoostKingfa Science & Technology (India) Limited ( NSE:KINGFA ) shares have continued their recent momentum with a 43% gain...Valuation Update With 7 Day Price Move • Aug 20Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₹3,573, the stock trades at a trailing P/E ratio of 34x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 234% over the past three years.お知らせ • Aug 09Kingfa Science & Technology (India) Limited Approves the Appointment of Mr. Ramachandran Sudhinder as an Independent DirectorKingfa Science & Technology (India) Limited approved the appointment of Mr. Ramachandran Sudhinder (DIN: 10628111) as an Independent Director.Reported Earnings • Aug 08First quarter 2025 earnings released: EPS: ₹32.26 (vs ₹28.93 in 1Q 2024)First quarter 2025 results: EPS: ₹32.26 (up from ₹28.93 in 1Q 2024). Revenue: ₹4.18b (up 24% from 1Q 2024). Net income: ₹390.7m (up 12% from 1Q 2024). Profit margin: 9.3% (down from 10% in 1Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 32% per year, which means it is significantly lagging earnings growth.お知らせ • Jul 29Kingfa Science & Technology (India) Limited to Report Q1, 2025 Results on Aug 07, 2024Kingfa Science & Technology (India) Limited announced that they will report Q1, 2025 results on Aug 07, 2024New Risk • Jul 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (23% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.9% average weekly change).Valuation Update With 7 Day Price Move • Jul 04Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹2,605, the stock trades at a trailing P/E ratio of 25.6x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 121% over the past three years.分析記事 • Jul 04Investors Still Aren't Entirely Convinced By Kingfa Science & Technology (India) Limited's (NSE:KINGFA) Earnings Despite 36% Price JumpThe Kingfa Science & Technology (India) Limited ( NSE:KINGFA ) share price has done very well over the last month...Valuation Update With 7 Day Price Move • Jun 18Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹2,202, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 122% over the past three years.分析記事 • Jun 05Kingfa Science & Technology (India)'s (NSE:KINGFA) Solid Profits Have Weak FundamentalsDespite posting some strong earnings, the market for Kingfa Science & Technology (India) Limited's ( NSE:KINGFA ) stock...New Risk • Jun 04New minor risk - Dividend sustainabilityThe company has a short dividend paying track record. Less than a year of continuous dividend payments. Dividend yield: 0.5% This is considered a minor risk. For dividend focussed investors, companies that have not established a long-term track record of consistently maintaining or growing dividends are less attractive than those companies that have a long track record. Those that have a long track record have proven their underlying business is stable enough to consistently maintain or grow the dividend and that the company considers maintaining the dividend to be one of its priorities. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (23% accrual ratio). Minor Risk Short dividend paying track record (less than a year of continuous dividend payments).お知らせ • May 30Kingfa Science & Technology (India) Limited Recommends Dividend for the Financial Year 2023-24Kingfa Science & Technology (India) Limited recommended a final dividend of 100% i.e., INR 10/- (Rupees Ten Only) per equity share of Face Value of INR 10/- each, for the financial year 2023-24. The final dividend, if approved, by Shareholders in the upcoming AGM, will be paid/dispatched to the eligible shareholders on or before 30th day from the date of 40th Annual General Meeting.Reported Earnings • May 30Full year 2024 earnings released: EPS: ₹101 (vs ₹67.22 in FY 2023)Full year 2024 results: EPS: ₹101 (up from ₹67.22 in FY 2023). Revenue: ₹14.9b (up 6.2% from FY 2023). Net income: ₹1.23b (up 51% from FY 2023). Profit margin: 8.2% (up from 5.8% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.お知らせ • May 22Kingfa Science & Technology (India) Limited to Report Q4, 2024 Results on May 28, 2024Kingfa Science & Technology (India) Limited announced that they will report Q4, 2024 results on May 28, 2024お知らせ • May 16Kingfa Science & Technology (India) Limited Announces Cessation of N. Subramanian as an Independent DirectorKingfa Science & Technology (India) Limited informed that the Board of Directors in their meeting held on May 15, 2024, has considered and approved the following: Mr. N. Subramanian has completed his second term of 5 (Five) years as an Independent Director and consequently ceased to be a Director of the Company with effect from the close of business hours on May 15, 2024.分析記事 • May 01Returns on Capital Paint A Bright Future For Kingfa Science & Technology (India) (NSE:KINGFA)If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Valuation Update With 7 Day Price Move • Mar 20Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹1,813, the stock trades at a trailing P/E ratio of 17.6x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 202% over the past three years.分析記事 • Mar 12Kingfa Science & Technology (India) Limited's (NSE:KINGFA) Subdued P/E Might Signal An OpportunityWith a price-to-earnings (or "P/E") ratio of 16.3x Kingfa Science & Technology (India) Limited ( NSE:KINGFA ) may be...Reported Earnings • Feb 07Third quarter 2024 earnings released: EPS: ₹20.09 (vs ₹16.71 in 3Q 2023)Third quarter 2024 results: EPS: ₹20.09 (up from ₹16.71 in 3Q 2023). Revenue: ₹3.95b (up 16% from 3Q 2023). Net income: ₹243.3m (up 20% from 3Q 2023). Profit margin: 6.2% (up from 6.0% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 49% per year, which means it is significantly lagging earnings growth.お知らせ • Jan 25Kingfa Science & Technology (India) Limited to Report Q3, 2024 Results on Feb 06, 2024Kingfa Science & Technology (India) Limited announced that they will report Q3, 2024 results on Feb 06, 2024Reported Earnings • Nov 10Second quarter 2024 earnings released: EPS: ₹24.44 (vs ₹18.24 in 2Q 2023)Second quarter 2024 results: EPS: ₹24.44 (up from ₹18.24 in 2Q 2023). Revenue: ₹3.51b (flat on 2Q 2023). Net income: ₹296.0m (up 34% from 2Q 2023). Profit margin: 8.4% (up from 6.3% in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has only increased by 60% per year, which means it is significantly lagging earnings growth.お知らせ • Oct 28Kingfa Science & Technology (India) Limited to Report Q2, 2024 Results on Nov 07, 2023Kingfa Science & Technology (India) Limited announced that they will report Q2, 2024 results on Nov 07, 2023New Risk • Oct 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.お知らせ • Aug 31Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 26, 2023Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 26, 2023, at 11:30 Indian Standard Time. Agenda: To consider Adoption of Audited Financial Statements of the Company for the Financial Year ended March 31, 2023; to consider re-appointment of Mr. Wu Xiaohui; to consider; to consider Approval for Payment of Commission to Independent Directors; to consider ratification of Remuneration to Cost Auditor and to consider such other matters.分析記事 • Aug 26Kingfa Science & Technology (India) (NSE:KINGFA) Is Very Good At Capital AllocationFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Reported Earnings • Aug 06First quarter 2024 earnings released: EPS: ₹28.93 (vs ₹2.04 in 1Q 2023)First quarter 2024 results: EPS: ₹28.93 (up from ₹2.04 in 1Q 2023). Revenue: ₹3.41b (down 1.4% from 1Q 2023). Net income: ₹350.4m (up ₹325.6m from 1Q 2023). Profit margin: 10% (up from 0.7% in 1Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 64% per year, which means it is significantly lagging earnings growth.お知らせ • Jul 29Kingfa Science & Technology (India) Limited to Report Q1, 2024 Results on Aug 05, 2023Kingfa Science & Technology (India) Limited announced that they will report Q1, 2024 results on Aug 05, 2023分析記事 • Jul 29If EPS Growth Is Important To You, Kingfa Science & Technology (India) (NSE:KINGFA) Presents An OpportunityInvestors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Reported Earnings • May 30Full year 2023 earnings released: EPS: ₹67.22 (vs ₹25.29 in FY 2022)Full year 2023 results: EPS: ₹67.22 (up from ₹25.29 in FY 2022). Revenue: ₹14.1b (up 34% from FY 2022). Net income: ₹814.1m (up 166% from FY 2022). Profit margin: 5.8% (up from 2.9% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has increased by 67% per year, which means it is tracking significantly ahead of earnings growth.分析記事 • May 26Kingfa Science & Technology (India) (NSE:KINGFA) Could Become A Multi-BaggerIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...Valuation Update With 7 Day Price Move • May 25Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹2,042, the stock trades at a trailing P/E ratio of 50.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 383% over the past three years.Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,539, the stock trades at a trailing P/E ratio of 38.2x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 282% over the past three years.Reported Earnings • Feb 17Third quarter 2023 earnings released: EPS: ₹16.71 (vs ₹6.16 in 3Q 2022)Third quarter 2023 results: EPS: ₹16.71 (up from ₹6.16 in 3Q 2022). Revenue: ₹3.39b (up 32% from 3Q 2022). Net income: ₹202.3m (up 171% from 3Q 2022). Profit margin: 6.0% (up from 2.9% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 28% per year whereas the company’s share price has increased by 27% per year.Valuation Update With 7 Day Price Move • Feb 13Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,440, the stock trades at a trailing P/E ratio of 48x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 144% over the past three years.分析記事 • Feb 11Kingfa Science & Technology (India) (NSE:KINGFA) Is Very Good At Capital AllocationWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...お知らせ • Feb 03Kingfa Science & Technology (India) Limited to Report Q3, 2023 Results on Feb 14, 2023Kingfa Science & Technology (India) Limited announced that they will report Q3, 2023 results on Feb 14, 2023分析記事 • Jan 01We Think Kingfa Science & Technology (India) (NSE:KINGFA) Can Stay On Top Of Its DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹18.24 (vs ₹6.15 in 2Q 2022)Second quarter 2023 results: EPS: ₹18.24 (up from ₹6.15 in 2Q 2022). Revenue: ₹3.51b (up 33% from 2Q 2022). Net income: ₹220.9m (up 197% from 2Q 2022). Profit margin: 6.3% (up from 2.8% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Executive Director Doraiswami Balaji was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 12Second quarter 2023 earnings released: EPS: ₹18.24 (vs ₹6.15 in 2Q 2022)Second quarter 2023 results: EPS: ₹18.24 (up from ₹6.15 in 2Q 2022). Revenue: ₹3.52b (up 33% from 2Q 2022). Net income: ₹220.9m (up 197% from 2Q 2022). Profit margin: 6.3% (up from 2.8% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Nov 03Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹1,224, the stock trades at a trailing P/E ratio of 69.8x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 82% over the past three years.Valuation Update With 7 Day Price Move • Aug 26Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₹1,231, the stock trades at a trailing P/E ratio of 62.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 101% over the past three years.分析記事 • Aug 12Kingfa Science & Technology (India) (NSE:KINGFA) Might Have The Makings Of A Multi-BaggerFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Reported Earnings • Aug 11First quarter 2023 earnings released: EPS: ₹2.04 (vs ₹9.68 in 1Q 2022)First quarter 2023 results: EPS: ₹2.04 (down from ₹9.68 in 1Q 2022). Revenue: ₹3.46b (up 56% from 1Q 2022). Net income: ₹24.7m (down 79% from 1Q 2022). Profit margin: 0.7% (down from 5.3% in 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹904, the stock trades at a trailing P/E ratio of 33.6x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 35% over the past three years.分析記事 • Jun 17Does Kingfa Science & Technology (India) (NSE:KINGFA) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • May 29Full year 2022 earnings released: EPS: ₹25.29 (vs ₹4.39 in FY 2021)Full year 2022 results: EPS: ₹25.29 (up from ₹4.39 in FY 2021). Revenue: ₹10.5b (up 67% from FY 2021). Net income: ₹306.3m (up 476% from FY 2021). Profit margin: 2.9% (up from 0.8% in FY 2021). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • May 11Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₹937, the stock trades at a trailing P/E ratio of 40.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 56% over the past three years.分析記事 • May 07Kingfa Science & Technology (India)'s (NSE:KINGFA) Returns On Capital Not Reflecting Well On The BusinessIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Executive Director Doraiswami Balaji was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹6.16 (up from ₹1.36 in 3Q 2021). Revenue: ₹2.56b (up 32% from 3Q 2021). Net income: ₹74.6m (up 354% from 3Q 2021). Profit margin: 2.9% (up from 0.8% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 30% per year, which means it is well ahead of earnings.分析記事 • Jan 25Does Kingfa Science & Technology (India) (NSE:KINGFA) Have A Healthy Balance Sheet?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 24% share price gain to ₹1,348, the stock trades at a trailing P/E ratio of 73x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 69% over the past three years.Valuation Update With 7 Day Price Move • Dec 14Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹1,086, the stock trades at a trailing P/E ratio of 55.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 51% over the past three years.Board Change • Nov 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Executive Director Doraiswami Balaji was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS ₹6.15 (vs ₹2.73 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹2.65b (up 58% from 2Q 2021). Net income: ₹74.5m (up 126% from 2Q 2021). Profit margin: 2.8% (up from 2.0% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.分析記事 • Mar 08We're Watching These Trends At Kingfa Science & Technology (India) (NSE:KINGFA)There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...Is New 90 Day High Low • Mar 05New 90-day high: ₹718The company is up 35% from its price of ₹533 on 04 December 2020. The Indian market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period.Reported Earnings • Feb 11Third quarter 2021 earnings released: EPS ₹1.36 (vs ₹6.29 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: ₹1.96b (up 3.8% from 3Q 2020). Net income: ₹16.5m (down 78% from 3Q 2020). Profit margin: 0.8% (down from 4.0% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 14% per year whereas the company’s share price has fallen by 16% per year.分析記事 • Feb 09Is Kingfa Science & Technology (India) (NSE:KINGFA) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Is New 90 Day High Low • Jan 19New 90-day high: ₹692The company is up 30% from its price of ₹532 on 21 October 2020. The Indian market is up 22% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period.分析記事 • Jan 13Kingfa Science & Technology (India) Limited's (NSE:KINGFA) Stock Is Going Strong: Have Financials A Role To Play?Kingfa Science & Technology (India)'s (NSE:KINGFA) stock is up by a considerable 25% over the past three months. We...Is New 90 Day High Low • Jan 04New 90-day high: ₹636The company is up 27% from its price of ₹500 on 06 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period.分析記事 • Dec 23Kingfa Science & Technology (India)'s (NSE:KINGFA) Stock Price Has Reduced 30% In The Past Three YearsWhile not a mind-blowing move, it is good to see that the Kingfa Science & Technology (India) Limited ( NSE:KINGFA...Valuation Update With 7 Day Price Move • Dec 15Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹619, the stock is trading at a trailing P/E ratio of 68x, up from the previous P/E ratio of 59.1x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 25%.収支内訳Kingfa Science & Technology (India) の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史NSEI:KINGFA 収益、費用、利益 ( )INR Millions日付収益収益G+A経費研究開発費31 Dec 2518,8661,680466030 Sep 2518,3751,575464030 Jun 2517,9021,536410031 Mar 2517,4471,529433031 Dec 2416,7961,445413030 Sep 2416,3301,342395030 Jun 2415,6551,266311031 Mar 2414,8771,225349031 Dec 2314,5081,256360030 Sep 2313,9611,215343030 Jun 2313,9651,140256031 Mar 2314,037814321031 Dec 2213,406488274030 Sep 2212,579360238030 Jun 2211,714214208031 Mar 2210,479306227031 Dec 219,646283201030 Sep 219,020224200030 Jun 218,044183177031 Mar 216,27253254031 Dec 205,85443224030 Sep 205,800103219030 Jun 206,027129154031 Mar 207,415246171031 Dec 197,430365127030 Sep 197,179342143030 Jun 197,157288114031 Mar 197,015191142031 Dec 186,924144182030 Sep 186,921173174030 Jun 186,449219169031 Mar 186,016246136031 Dec 175,461207151030 Sep 174,933139148030 Jun 174,655129128031 Mar 174,271124141031 Dec 164,000134127030 Sep 163,650159118030 Jun 163,395139101031 Mar 163,142108104031 Dec 152,814672161730 Sep 152,600122141730 Jun 152,305-2521217質の高い収益: KINGFAは 高品質の収益 を持っています。利益率の向上: KINGFAの現在の純利益率 (8.9%)は、昨年(8.6%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: KINGFAの収益は過去 5 年間で年間42.5%増加しました。成長の加速: KINGFAの過去 1 年間の収益成長率 ( 16.3% ) は、5 年間の平均 ( 年間42.5%を下回っています。収益対業界: KINGFAの過去 1 年間の収益成長率 ( 16.3% ) はChemicals業界10.1%を上回りました。株主資本利益率高いROE: KINGFAの 自己資本利益率 ( 13% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/23 21:30終値2026/05/22 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Kingfa Science & Technology (India) Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Kameswari V. S. ChavaliFirstCall Research
Reported Earnings • Feb 08Third quarter 2026 earnings released: EPS: ₹33.34 (vs ₹28.59 in 3Q 2025)Third quarter 2026 results: EPS: ₹33.34 (up from ₹28.59 in 3Q 2025). Revenue: ₹4.89b (up 11% from 3Q 2025). Net income: ₹451.7m (up 31% from 3Q 2025). Profit margin: 9.2% (up from 7.9% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Feb 02Kingfa Science & Technology (India) Limited to Report Q3, 2026 Results on Feb 07, 2026Kingfa Science & Technology (India) Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 07, 2026
分析記事 • Nov 20Kingfa Science & Technology (India)'s (NSE:KINGFA) Earnings Are Weaker Than They SeemDespite announcing strong earnings, Kingfa Science & Technology (India) Limited's ( NSE:KINGFA ) stock was sluggish. We...
Reported Earnings • Nov 14Second quarter 2026 earnings released: EPS: ₹30.36 (vs ₹30.76 in 2Q 2025)Second quarter 2026 results: EPS: ₹30.36. Revenue: ₹4.68b (up 12% from 2Q 2025). Net income: ₹411.4m (up 10% from 2Q 2025). Profit margin: 8.8% (down from 8.9% in 2Q 2025). The decrease in margin was driven by higher expenses.
お知らせ • Nov 07Kingfa Science & Technology (India) Limited to Report Q2, 2026 Results on Nov 12, 2025Kingfa Science & Technology (India) Limited announced that they will report Q2, 2026 results on Nov 12, 2025
Reported Earnings • Jul 31First quarter 2026 earnings released: EPS: ₹32.86 (vs ₹32.27 in 1Q 2025)First quarter 2026 results: EPS: ₹32.86 (up from ₹32.27 in 1Q 2025). Revenue: ₹4.66b (up 12% from 1Q 2025). Net income: ₹397.9m (up 1.8% from 1Q 2025). Profit margin: 8.5% (down from 9.4% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Feb 08Third quarter 2026 earnings released: EPS: ₹33.34 (vs ₹28.59 in 3Q 2025)Third quarter 2026 results: EPS: ₹33.34 (up from ₹28.59 in 3Q 2025). Revenue: ₹4.89b (up 11% from 3Q 2025). Net income: ₹451.7m (up 31% from 3Q 2025). Profit margin: 9.2% (up from 7.9% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Feb 02Kingfa Science & Technology (India) Limited to Report Q3, 2026 Results on Feb 07, 2026Kingfa Science & Technology (India) Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 07, 2026
Buy Or Sell Opportunity • Jan 29Now 20% overvaluedOver the last 90 days, the stock has fallen 9.1% to ₹4,225. The fair value is estimated to be ₹3,515, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.
分析記事 • Dec 23Kingfa Science & Technology (India) Limited (NSE:KINGFA) Not Flying Under The RadarKingfa Science & Technology (India) Limited's ( NSE:KINGFA ) price-to-earnings (or "P/E") ratio of 37x might make it...
Buy Or Sell Opportunity • Dec 22Now 20% overvaluedOver the last 90 days, the stock has fallen 2.3% to ₹4,284. The fair value is estimated to be ₹3,567, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.
分析記事 • Dec 05Kingfa Science & Technology (India) (NSE:KINGFA) Is Doing The Right Things To Multiply Its Share PriceIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Buy Or Sell Opportunity • Nov 27Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 5.0% to ₹4,382. The fair value is estimated to be ₹3,589, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.
分析記事 • Nov 20Kingfa Science & Technology (India)'s (NSE:KINGFA) Earnings Are Weaker Than They SeemDespite announcing strong earnings, Kingfa Science & Technology (India) Limited's ( NSE:KINGFA ) stock was sluggish. We...
Reported Earnings • Nov 14Second quarter 2026 earnings released: EPS: ₹30.36 (vs ₹30.76 in 2Q 2025)Second quarter 2026 results: EPS: ₹30.36. Revenue: ₹4.68b (up 12% from 2Q 2025). Net income: ₹411.4m (up 10% from 2Q 2025). Profit margin: 8.8% (down from 8.9% in 2Q 2025). The decrease in margin was driven by higher expenses.
お知らせ • Nov 07Kingfa Science & Technology (India) Limited to Report Q2, 2026 Results on Nov 12, 2025Kingfa Science & Technology (India) Limited announced that they will report Q2, 2026 results on Nov 12, 2025
お知らせ • Sep 30Kingfa Science & Technology (India) Limited Approves Appointment of Subramanyan S. K. as A Non-Executive Independent DirectorKingfa Science & Technology (India) Limited announced that at the AGM held on September 29, 2025, approved appointment of Mr. Subramanyan S. K. (DIN:00024614) as a Non-Executive Independent Director.
お知らせ • Sep 25Kingfa Science & Technology (India) Limited announced that it has received INR 4.9999924 billion in funding from Sanshi Fund - I, Custody Bank of Japan, Ltd. RE: RB Amundi Small Cap Equity Mother Fund, SBI Optimal Equity Fund - Long Term, SBI Funds Management LimitedOn September 24, 2025, Kingfa Science & Technology (India) Limited closed the transaction. The company issued 1,440,920 equity shares at an issue price of INR 3,470 for gross proceeds of INR 4,999,992,400. The transaction includes participation from new investors, Sanshi Fund - I for 72,046 shares and will acquire 0.53% stake, SBI Mutual Fund - SBI Flexicap Fund, a fund managed by SBI Funds Management Limited for 345,821 shares and will acquire 2.55% stake, SBI Funds Management Limited - SBI Automotive Opportunities Fund, a fund managed by SBI Funds Management Limited for 184,438 shares and will acquire 1.36% stake, SBI Conservative Hybrid Fund, a fund managed by SBI Funds Management Limited for 357,348 shares and will acquire 2.64% stake, Custody Bank of Japan, Ltd. RE: RB Amundi Small Cap Equity Mother Fund for 273,775 shares and will acquire 2.02% stake, SBI Optimal Equity Fund - Long Term for 100,864 shares and will acquire 0.74% stake and Sbi Emergent India Fund, a fund managed by SBI Funds Management Limited for 106,628 shares and will acquire 0.79% stake. The transaction has been approved by the board of directors.
New Risk • Sep 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
お知らせ • Aug 25Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 29, 2025Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 29, 2025, at 11:30 Indian Standard Time.
分析記事 • Aug 20Kingfa Science & Technology (India) Limited (NSE:KINGFA) Looks Just Right With A 27% Price JumpNSEI:KINGFA 1 Year Share Price vs Fair Value Explore Kingfa Science & Technology (India)'s Fair Values from the...
Valuation Update With 7 Day Price Move • Aug 18Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹4,145, the stock trades at a trailing P/E ratio of 32.7x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 328% over the past three years.
分析記事 • Aug 02We Like Kingfa Science & Technology (India)'s (NSE:KINGFA) Returns And Here's How They're TrendingDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...
Reported Earnings • Jul 31First quarter 2026 earnings released: EPS: ₹32.86 (vs ₹32.27 in 1Q 2025)First quarter 2026 results: EPS: ₹32.86 (up from ₹32.27 in 1Q 2025). Revenue: ₹4.66b (up 12% from 1Q 2025). Net income: ₹397.9m (up 1.8% from 1Q 2025). Profit margin: 8.5% (down from 9.4% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jul 23Kingfa Science & Technology (India) Limited to Report Q1, 2026 Results on Jul 30, 2025Kingfa Science & Technology (India) Limited announced that they will report Q1, 2026 results on Jul 30, 2025
分析記事 • Jul 01Kingfa Science & Technology (India) Limited's (NSE:KINGFA) Subdued P/E Might Signal An OpportunityThere wouldn't be many who think Kingfa Science & Technology (India) Limited's ( NSE:KINGFA ) price-to-earnings (or...
Reported Earnings • May 29Full year 2025 earnings released: EPS: ₹126 (vs ₹101 in FY 2024)Full year 2025 results: EPS: ₹126 (up from ₹101 in FY 2024). Revenue: ₹17.5b (up 18% from FY 2024). Net income: ₹1.53b (up 25% from FY 2024). Profit margin: 8.7% (up from 8.2% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 47% per year whereas the company’s share price has increased by 52% per year.
お知らせ • May 20Kingfa Science & Technology (India) Limited to Report Q4, 2025 Results on May 28, 2025Kingfa Science & Technology (India) Limited announced that they will report Q4, 2025 results on May 28, 2025
お知らせ • Apr 01Kingfa Science & Technology (India) Limited Announces Resignation of Nirnoy Sur as Company Secretary & Compliance Officer, Effective March 31, 2025Kingfa Science & Technology (India) Limited informed that Mr. Nirnoy Sur has resigned as Company Secretary & Compliance Officer of the Company with effect from March 31,2025. Mr. Nirnoy Sur has tendered his resignation from the position of Company Secretary (Key Managerial Personnel), Compliance Officer and Nodal Officer of the Company vide letter dated February 11, 2025, due to his personal reasons and to pursue professional growth opportunities.
Reported Earnings • Feb 13Third quarter 2025 earnings released: EPS: ₹28.59 (vs ₹20.09 in 3Q 2024)Third quarter 2025 results: EPS: ₹28.59 (up from ₹20.09 in 3Q 2024). Revenue: ₹4.40b (up 12% from 3Q 2024). Net income: ₹346.3m (up 42% from 3Q 2024). Profit margin: 7.9% (up from 6.2% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 11Kingfa Science & Technology (India) Limited Announces Resignation of Nirnoy Sur as Company Secretary, Effective March 31, 2025Kingfa Science & Technology (India) Limited approved Resignation of Mr. Nirnoy Sur as Company Secretary & Compliance Officer of the Company. Reason for Change: Resignation, due to his personal reasons and to pursue professional growth opportunities. Date of Cessation: March 31, 2025. Resignation letter date: February 11, 2025.
お知らせ • Feb 03Kingfa Science & Technology (India) Limited to Report Q3, 2025 Results on Feb 11, 2025Kingfa Science & Technology (India) Limited announced that they will report Q3, 2025 results on Feb 11, 2025
分析記事 • Jan 15Here's Why Kingfa Science & Technology (India) (NSE:KINGFA) Can Manage Its Debt ResponsiblyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
分析記事 • Dec 24We Like Kingfa Science & Technology (India)'s (NSE:KINGFA) Returns And Here's How They're TrendingTo find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...
Valuation Update With 7 Day Price Move • Dec 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹3,363, the stock trades at a trailing P/E ratio of 30.3x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 265% over the past three years.
分析記事 • Dec 04Kingfa Science & Technology (India) Limited (NSE:KINGFA) Might Not Be As Mispriced As It LooksThere wouldn't be many who think Kingfa Science & Technology (India) Limited's ( NSE:KINGFA ) price-to-earnings (or...
Reported Earnings • Oct 30Second quarter 2025 earnings released: EPS: ₹30.76 (vs ₹24.44 in 2Q 2024)Second quarter 2025 results: EPS: ₹30.76 (up from ₹24.44 in 2Q 2024). Revenue: ₹4.19b (up 20% from 2Q 2024). Net income: ₹372.6m (up 26% from 2Q 2024). Profit margin: 8.9% (up from 8.4% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 47% per year, which means it is significantly lagging earnings growth.
お知らせ • Oct 21Kingfa Science & Technology (India) Limited to Report Q2, 2025 Results on Oct 29, 2024Kingfa Science & Technology (India) Limited announced that they will report Q2, 2025 results on Oct 29, 2024
お知らせ • Sep 26Kingfa Science & Technology (India) Limited Approves Dividend for the Financial Year Ended March 31, 2024Kingfa Science & Technology (India) Limited at its AGM held on 25 September 2024 approved, Declaration of Dividend of INR 10/- per Equity Share of the face value of INR 10/- each (100%), of the Company for the financial year ended March 31, 2024.
Upcoming Dividend • Sep 11Upcoming dividend of ₹10.00 per shareEligible shareholders must have bought the stock before 18 September 2024. Payment date: 24 October 2024. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.0%). Lower than average of industry peers (0.6%).
お知らせ • Aug 29Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 25, 2024Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 25, 2024, at 11:30 Indian Standard Time.
分析記事 • Aug 21Market Might Still Lack Some Conviction On Kingfa Science & Technology (India) Limited (NSE:KINGFA) Even After 43% Share Price BoostKingfa Science & Technology (India) Limited ( NSE:KINGFA ) shares have continued their recent momentum with a 43% gain...
Valuation Update With 7 Day Price Move • Aug 20Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₹3,573, the stock trades at a trailing P/E ratio of 34x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 234% over the past three years.
お知らせ • Aug 09Kingfa Science & Technology (India) Limited Approves the Appointment of Mr. Ramachandran Sudhinder as an Independent DirectorKingfa Science & Technology (India) Limited approved the appointment of Mr. Ramachandran Sudhinder (DIN: 10628111) as an Independent Director.
Reported Earnings • Aug 08First quarter 2025 earnings released: EPS: ₹32.26 (vs ₹28.93 in 1Q 2024)First quarter 2025 results: EPS: ₹32.26 (up from ₹28.93 in 1Q 2024). Revenue: ₹4.18b (up 24% from 1Q 2024). Net income: ₹390.7m (up 12% from 1Q 2024). Profit margin: 9.3% (down from 10% in 1Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 32% per year, which means it is significantly lagging earnings growth.
お知らせ • Jul 29Kingfa Science & Technology (India) Limited to Report Q1, 2025 Results on Aug 07, 2024Kingfa Science & Technology (India) Limited announced that they will report Q1, 2025 results on Aug 07, 2024
New Risk • Jul 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (23% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.9% average weekly change).
Valuation Update With 7 Day Price Move • Jul 04Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹2,605, the stock trades at a trailing P/E ratio of 25.6x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 121% over the past three years.
分析記事 • Jul 04Investors Still Aren't Entirely Convinced By Kingfa Science & Technology (India) Limited's (NSE:KINGFA) Earnings Despite 36% Price JumpThe Kingfa Science & Technology (India) Limited ( NSE:KINGFA ) share price has done very well over the last month...
Valuation Update With 7 Day Price Move • Jun 18Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹2,202, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 122% over the past three years.
分析記事 • Jun 05Kingfa Science & Technology (India)'s (NSE:KINGFA) Solid Profits Have Weak FundamentalsDespite posting some strong earnings, the market for Kingfa Science & Technology (India) Limited's ( NSE:KINGFA ) stock...
New Risk • Jun 04New minor risk - Dividend sustainabilityThe company has a short dividend paying track record. Less than a year of continuous dividend payments. Dividend yield: 0.5% This is considered a minor risk. For dividend focussed investors, companies that have not established a long-term track record of consistently maintaining or growing dividends are less attractive than those companies that have a long track record. Those that have a long track record have proven their underlying business is stable enough to consistently maintain or grow the dividend and that the company considers maintaining the dividend to be one of its priorities. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (23% accrual ratio). Minor Risk Short dividend paying track record (less than a year of continuous dividend payments).
お知らせ • May 30Kingfa Science & Technology (India) Limited Recommends Dividend for the Financial Year 2023-24Kingfa Science & Technology (India) Limited recommended a final dividend of 100% i.e., INR 10/- (Rupees Ten Only) per equity share of Face Value of INR 10/- each, for the financial year 2023-24. The final dividend, if approved, by Shareholders in the upcoming AGM, will be paid/dispatched to the eligible shareholders on or before 30th day from the date of 40th Annual General Meeting.
Reported Earnings • May 30Full year 2024 earnings released: EPS: ₹101 (vs ₹67.22 in FY 2023)Full year 2024 results: EPS: ₹101 (up from ₹67.22 in FY 2023). Revenue: ₹14.9b (up 6.2% from FY 2023). Net income: ₹1.23b (up 51% from FY 2023). Profit margin: 8.2% (up from 5.8% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.
お知らせ • May 22Kingfa Science & Technology (India) Limited to Report Q4, 2024 Results on May 28, 2024Kingfa Science & Technology (India) Limited announced that they will report Q4, 2024 results on May 28, 2024
お知らせ • May 16Kingfa Science & Technology (India) Limited Announces Cessation of N. Subramanian as an Independent DirectorKingfa Science & Technology (India) Limited informed that the Board of Directors in their meeting held on May 15, 2024, has considered and approved the following: Mr. N. Subramanian has completed his second term of 5 (Five) years as an Independent Director and consequently ceased to be a Director of the Company with effect from the close of business hours on May 15, 2024.
分析記事 • May 01Returns on Capital Paint A Bright Future For Kingfa Science & Technology (India) (NSE:KINGFA)If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Valuation Update With 7 Day Price Move • Mar 20Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹1,813, the stock trades at a trailing P/E ratio of 17.6x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 202% over the past three years.
分析記事 • Mar 12Kingfa Science & Technology (India) Limited's (NSE:KINGFA) Subdued P/E Might Signal An OpportunityWith a price-to-earnings (or "P/E") ratio of 16.3x Kingfa Science & Technology (India) Limited ( NSE:KINGFA ) may be...
Reported Earnings • Feb 07Third quarter 2024 earnings released: EPS: ₹20.09 (vs ₹16.71 in 3Q 2023)Third quarter 2024 results: EPS: ₹20.09 (up from ₹16.71 in 3Q 2023). Revenue: ₹3.95b (up 16% from 3Q 2023). Net income: ₹243.3m (up 20% from 3Q 2023). Profit margin: 6.2% (up from 6.0% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 49% per year, which means it is significantly lagging earnings growth.
お知らせ • Jan 25Kingfa Science & Technology (India) Limited to Report Q3, 2024 Results on Feb 06, 2024Kingfa Science & Technology (India) Limited announced that they will report Q3, 2024 results on Feb 06, 2024
Reported Earnings • Nov 10Second quarter 2024 earnings released: EPS: ₹24.44 (vs ₹18.24 in 2Q 2023)Second quarter 2024 results: EPS: ₹24.44 (up from ₹18.24 in 2Q 2023). Revenue: ₹3.51b (flat on 2Q 2023). Net income: ₹296.0m (up 34% from 2Q 2023). Profit margin: 8.4% (up from 6.3% in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has only increased by 60% per year, which means it is significantly lagging earnings growth.
お知らせ • Oct 28Kingfa Science & Technology (India) Limited to Report Q2, 2024 Results on Nov 07, 2023Kingfa Science & Technology (India) Limited announced that they will report Q2, 2024 results on Nov 07, 2023
New Risk • Oct 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
お知らせ • Aug 31Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 26, 2023Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 26, 2023, at 11:30 Indian Standard Time. Agenda: To consider Adoption of Audited Financial Statements of the Company for the Financial Year ended March 31, 2023; to consider re-appointment of Mr. Wu Xiaohui; to consider; to consider Approval for Payment of Commission to Independent Directors; to consider ratification of Remuneration to Cost Auditor and to consider such other matters.
分析記事 • Aug 26Kingfa Science & Technology (India) (NSE:KINGFA) Is Very Good At Capital AllocationFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Reported Earnings • Aug 06First quarter 2024 earnings released: EPS: ₹28.93 (vs ₹2.04 in 1Q 2023)First quarter 2024 results: EPS: ₹28.93 (up from ₹2.04 in 1Q 2023). Revenue: ₹3.41b (down 1.4% from 1Q 2023). Net income: ₹350.4m (up ₹325.6m from 1Q 2023). Profit margin: 10% (up from 0.7% in 1Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 64% per year, which means it is significantly lagging earnings growth.
お知らせ • Jul 29Kingfa Science & Technology (India) Limited to Report Q1, 2024 Results on Aug 05, 2023Kingfa Science & Technology (India) Limited announced that they will report Q1, 2024 results on Aug 05, 2023
分析記事 • Jul 29If EPS Growth Is Important To You, Kingfa Science & Technology (India) (NSE:KINGFA) Presents An OpportunityInvestors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Reported Earnings • May 30Full year 2023 earnings released: EPS: ₹67.22 (vs ₹25.29 in FY 2022)Full year 2023 results: EPS: ₹67.22 (up from ₹25.29 in FY 2022). Revenue: ₹14.1b (up 34% from FY 2022). Net income: ₹814.1m (up 166% from FY 2022). Profit margin: 5.8% (up from 2.9% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has increased by 67% per year, which means it is tracking significantly ahead of earnings growth.
分析記事 • May 26Kingfa Science & Technology (India) (NSE:KINGFA) Could Become A Multi-BaggerIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...
Valuation Update With 7 Day Price Move • May 25Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹2,042, the stock trades at a trailing P/E ratio of 50.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 383% over the past three years.
Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,539, the stock trades at a trailing P/E ratio of 38.2x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 282% over the past three years.
Reported Earnings • Feb 17Third quarter 2023 earnings released: EPS: ₹16.71 (vs ₹6.16 in 3Q 2022)Third quarter 2023 results: EPS: ₹16.71 (up from ₹6.16 in 3Q 2022). Revenue: ₹3.39b (up 32% from 3Q 2022). Net income: ₹202.3m (up 171% from 3Q 2022). Profit margin: 6.0% (up from 2.9% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 28% per year whereas the company’s share price has increased by 27% per year.
Valuation Update With 7 Day Price Move • Feb 13Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,440, the stock trades at a trailing P/E ratio of 48x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 144% over the past three years.
分析記事 • Feb 11Kingfa Science & Technology (India) (NSE:KINGFA) Is Very Good At Capital AllocationWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...
お知らせ • Feb 03Kingfa Science & Technology (India) Limited to Report Q3, 2023 Results on Feb 14, 2023Kingfa Science & Technology (India) Limited announced that they will report Q3, 2023 results on Feb 14, 2023
分析記事 • Jan 01We Think Kingfa Science & Technology (India) (NSE:KINGFA) Can Stay On Top Of Its DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹18.24 (vs ₹6.15 in 2Q 2022)Second quarter 2023 results: EPS: ₹18.24 (up from ₹6.15 in 2Q 2022). Revenue: ₹3.51b (up 33% from 2Q 2022). Net income: ₹220.9m (up 197% from 2Q 2022). Profit margin: 6.3% (up from 2.8% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Executive Director Doraiswami Balaji was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 12Second quarter 2023 earnings released: EPS: ₹18.24 (vs ₹6.15 in 2Q 2022)Second quarter 2023 results: EPS: ₹18.24 (up from ₹6.15 in 2Q 2022). Revenue: ₹3.52b (up 33% from 2Q 2022). Net income: ₹220.9m (up 197% from 2Q 2022). Profit margin: 6.3% (up from 2.8% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Nov 03Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹1,224, the stock trades at a trailing P/E ratio of 69.8x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 82% over the past three years.
Valuation Update With 7 Day Price Move • Aug 26Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₹1,231, the stock trades at a trailing P/E ratio of 62.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 101% over the past three years.
分析記事 • Aug 12Kingfa Science & Technology (India) (NSE:KINGFA) Might Have The Makings Of A Multi-BaggerFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Reported Earnings • Aug 11First quarter 2023 earnings released: EPS: ₹2.04 (vs ₹9.68 in 1Q 2022)First quarter 2023 results: EPS: ₹2.04 (down from ₹9.68 in 1Q 2022). Revenue: ₹3.46b (up 56% from 1Q 2022). Net income: ₹24.7m (down 79% from 1Q 2022). Profit margin: 0.7% (down from 5.3% in 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹904, the stock trades at a trailing P/E ratio of 33.6x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 35% over the past three years.
分析記事 • Jun 17Does Kingfa Science & Technology (India) (NSE:KINGFA) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • May 29Full year 2022 earnings released: EPS: ₹25.29 (vs ₹4.39 in FY 2021)Full year 2022 results: EPS: ₹25.29 (up from ₹4.39 in FY 2021). Revenue: ₹10.5b (up 67% from FY 2021). Net income: ₹306.3m (up 476% from FY 2021). Profit margin: 2.9% (up from 0.8% in FY 2021). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • May 11Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₹937, the stock trades at a trailing P/E ratio of 40.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 56% over the past three years.
分析記事 • May 07Kingfa Science & Technology (India)'s (NSE:KINGFA) Returns On Capital Not Reflecting Well On The BusinessIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Executive Director Doraiswami Balaji was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹6.16 (up from ₹1.36 in 3Q 2021). Revenue: ₹2.56b (up 32% from 3Q 2021). Net income: ₹74.6m (up 354% from 3Q 2021). Profit margin: 2.9% (up from 0.8% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 30% per year, which means it is well ahead of earnings.
分析記事 • Jan 25Does Kingfa Science & Technology (India) (NSE:KINGFA) Have A Healthy Balance Sheet?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 24% share price gain to ₹1,348, the stock trades at a trailing P/E ratio of 73x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 69% over the past three years.
Valuation Update With 7 Day Price Move • Dec 14Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹1,086, the stock trades at a trailing P/E ratio of 55.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 51% over the past three years.
Board Change • Nov 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Executive Director Doraiswami Balaji was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS ₹6.15 (vs ₹2.73 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹2.65b (up 58% from 2Q 2021). Net income: ₹74.5m (up 126% from 2Q 2021). Profit margin: 2.8% (up from 2.0% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
分析記事 • Mar 08We're Watching These Trends At Kingfa Science & Technology (India) (NSE:KINGFA)There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...
Is New 90 Day High Low • Mar 05New 90-day high: ₹718The company is up 35% from its price of ₹533 on 04 December 2020. The Indian market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period.
Reported Earnings • Feb 11Third quarter 2021 earnings released: EPS ₹1.36 (vs ₹6.29 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: ₹1.96b (up 3.8% from 3Q 2020). Net income: ₹16.5m (down 78% from 3Q 2020). Profit margin: 0.8% (down from 4.0% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 14% per year whereas the company’s share price has fallen by 16% per year.
分析記事 • Feb 09Is Kingfa Science & Technology (India) (NSE:KINGFA) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Is New 90 Day High Low • Jan 19New 90-day high: ₹692The company is up 30% from its price of ₹532 on 21 October 2020. The Indian market is up 22% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period.
分析記事 • Jan 13Kingfa Science & Technology (India) Limited's (NSE:KINGFA) Stock Is Going Strong: Have Financials A Role To Play?Kingfa Science & Technology (India)'s (NSE:KINGFA) stock is up by a considerable 25% over the past three months. We...
Is New 90 Day High Low • Jan 04New 90-day high: ₹636The company is up 27% from its price of ₹500 on 06 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period.
分析記事 • Dec 23Kingfa Science & Technology (India)'s (NSE:KINGFA) Stock Price Has Reduced 30% In The Past Three YearsWhile not a mind-blowing move, it is good to see that the Kingfa Science & Technology (India) Limited ( NSE:KINGFA...
Valuation Update With 7 Day Price Move • Dec 15Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹619, the stock is trading at a trailing P/E ratio of 68x, up from the previous P/E ratio of 59.1x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 25%.